BetterLife Pharma (STU:NPAU) Total Stockholders Equity : €-7.39 Mil (As of Jan. 2024)

View and export this data going back to 2018. Start your Free Trial

What is BetterLife Pharma Total Stockholders Equity?

BetterLife Pharma's Total Stockholders Equity for the quarter that ended in Jan. 2024 was €-7.39 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. BetterLife Pharma's Book Value per Share for the quarter that ended in Jan. 2024 was €-0.06. The ratio of a company's debt over equity can be used to measure how leveraged this company is. BetterLife Pharma's Debt-to-Equity for the quarter that ended in Jan. 2024 was -0.14.

BetterLife Pharma Total Stockholders Equity Historical Data

The historical data trend for BetterLife Pharma's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BetterLife Pharma Total Stockholders Equity Chart

BetterLife Pharma Annual Data

Trend

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Jan24

Total Stockholders Equity

Get a 7-Day Free Trial

1.83

-2.98

-2.72

-7.42

-7.39

BetterLife Pharma Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Total Stockholders Equity	Get a 7-Day Free Trial															-7.42	-6.09	-6.50	-6.34	-7.39

BetterLife Pharma (STU:NPAU) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

BetterLife Pharma's Book Value per Share for the quarter that ended in Jan. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-7.392	-	0)	/	115.825
	=	-0.06

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

BetterLife Pharma's Debt-to-Equity for the quarter that ended in Jan. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.376	+	0.629)	/	-7.392
	=	-0.14

BetterLife Pharma Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of BetterLife Pharma's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

BetterLife Pharma (STU:NPAU) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BetterLife Pharma Inc (STU:NPAU) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

BETRF:USA NPAU:Germany BETR:Canada

Address

1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6

Website

https://www.abetterlifepharma.com

BetterLife Pharma Inc a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and European Union. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease and human papillomavirus, and/or to directly inhibit tumors to treat various types of cancer.

BetterLife Pharma (STU:NPAU) Headlines

No Headlines